Discharge Policy and Reperfusion Therapy in Acute Myocardial Infarction
Publisher: Erasmus University Rotterdam
textabstractTreatment of patients with acute myocardial infarction (MI) has improved over time and the duration of hospital stay has considerably decreased. Early hospital discharge after MI has been promoted for over 25 years. However, the meaning of “early” evolved ov... View more
Julian DG. Treatment of cardiac arrest in acute myocardial ischaemia and infarction. Lancet 1961;2:840-4.
Swann HK. Cooperative study on cardiac catheterization. Infectious, inflammatory, and allergic complications. Circulation 1968;37:1-101.
Simoons ML, Serruys PW, vd Brand M, et al. Improved survival after early thrombolysis in acute myocardial infarction. A randomised trial by the Interuniversity Cardiology Institute in The Netherlands. Lancet 1985;2:578-82.
The Reperfusion Therapy Consensus Group. Selection of reperfusion therapy for individual patients with evolving myocardial infarction. Eur Heart J 1997;18:1371-81.
Vermeer F, Simoons ML, Bär FW, et al. Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase? Circulation 1986;74:1379-89.
de Boer MJ et al. Limitation of infarct size and preservation of left ventricular function after primary coronary angioplasty compared with intravenous streptokinase in acute myocardial infarction. Circulation 1994;90:753-61.
Lamfers EJ, Schut A, Hooghoudt TE, et al. Prehospital thrombolysis with reteplase: the Nijmegen/Rotterdam study. Am Heart J 2003;146:479-83.
Grijseels EW, Bouten MJ, Lenderink T et al. Pre-hospital thrombolytic therapy with either alteplase or streptokinase. Practical applications, complications and long-term results in 529 patients. Eur Heart J 1995;16:1833-8.